Skip to main content
森萱医药 logo

森萱医药 — Investor Relations & Filings

Ticker · 920946 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2025-08-28 Governance Information
Country CN China
Listing Beijing Stock Exchange 920946

About 森萱医药

https://www.senxuan.cn/

Jiangsu Senxuan Pharmaceutical Co., Ltd. specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and specialized fine chemicals. The company’s product portfolio includes key intermediates for antiviral medications, such as those used in the treatment of HIV, and anticonvulsant agents like Primidone. Additionally, it produces high-purity chemical solvents including 1,4-dioxane and 1,3-dioxolane for diverse industrial applications. Senxuan Pharmaceutical maintains a focus on advanced chemical synthesis and large-scale manufacturing capabilities, adhering to international quality standards to support the global life sciences and chemical sectors. Its operations are characterized by a commitment to technical innovation and the supply of critical chemical building blocks for complex therapeutic formulations.

Recent filings

Filing Released Lang Actions
年报信息披露重大差错责任追究制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document from Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding the responsibility system for major errors in annual report information disclosure. It outlines principles, standards for identifying major errors in annual reports, procedures for accountability, and disciplinary measures. The document is not an annual report itself, nor is it an announcement of a report publication. It is not a certification or a brief announcement but a comprehensive governance-related policy document concerning annual report disclosures and accountability. Therefore, it fits best under Governance Information (CGR), as it details internal rules and governance practices related to annual report disclosures.
2025-08-28 Chinese
独立董事专门会议工作制度
Governance Information Classification · 95% confidence The document is titled as a work system for the Independent Directors' Special Meeting of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the procedures, powers, and responsibilities of independent directors in company governance, including meeting convening, voting, and reporting. It references company laws, securities laws, and stock exchange listing rules. The document is a governance-related internal regulation and does not contain financial statements, earnings data, or audit results. It is not an announcement of a report but a detailed governance policy document. Therefore, it fits best under Governance Information (CGR). The document length is 3058 characters, which is sufficient for a detailed governance report but not a full annual or interim report.
2025-08-28 Chinese
董事、高级管理人员持股变动管理制度
Director's Dealing Classification · 95% confidence The document is an announcement from Jiangsu Senxuan Pharmaceutical Co., Ltd. regarding the management system for shareholding changes by directors and senior management. It details internal rules and restrictions on share transactions by company insiders, referencing relevant laws and regulatory requirements. There is no financial data, earnings information, or report publication mentioned. The content focuses on governance and management of insider shareholding changes, which aligns with the category of Director's Dealing (DIRS). The document length is 4068 characters, which is relatively short but contains substantive content about insider shareholding management rather than a mere announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2025-08-28 Chinese
董事会提名委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Work Rules of the Board Nomination Committee' of Jiangsu Senxuan Pharmaceutical Co., Ltd. It details the composition, responsibilities, procedures, and rules of the Nomination Committee under the Board of Directors. It includes sections on the committee's formation, duties, meeting procedures, and confidentiality obligations. There is no financial data, earnings information, or report publication mentioned. The document is a governance-related internal regulation and policy document concerning board and senior management nomination processes. Therefore, it fits best under the category of Governance Information (CGR). The document length is 3801 characters, which is consistent with a detailed governance policy document rather than a brief announcement or report publication.
2025-08-28 Chinese
董事、高级管理人员薪酬管理办法
Remuneration Information Classification · 95% confidence The document is a detailed announcement regarding the management and regulation of remuneration for the company's directors and senior management personnel. It includes the principles, standards, assessment methods, and payment procedures for their compensation. The document references the board meeting where the remuneration management method was approved and states that it will be submitted to the shareholders' meeting for approval. There is no financial data, earnings information, or report publication mentioned. The content is focused on governance and compensation policies for executives, which aligns with Remuneration Information filings. The document length is under 5,000 characters but contains substantive policy details, not just an announcement of a report publication. Therefore, it is classified as Remuneration Information (DEF 14A).
2025-08-28 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled '江苏森萱医药股份有限公司董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors of Jiangsu Senxuan Pharmaceutical Co., Ltd.' It details the internal governance rules, procedures for board meetings, board composition, powers, voting rules, and other governance-related matters. There is no financial data, no audit information, no earnings or capital updates, no voting results, no legal proceedings, and no mention of report publication or announcements. The content is focused on the internal rules and governance structure of the board of directors. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial (over 11,000 characters), indicating it is the full text of the governance rules, not a brief announcement or summary.
2025-08-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.